Use Cases

Based on the following which was used by the GLUE-WG - but maybe we need something different for parameter sweeping!:

Description:  A short description of the use case
Actors:       Roles involved in the use case
Conversation: Sentences that help the understanding of the use case
Acceptance:   How to test the use case
Endorsed by:  The project supporting the use case

Tracker items (others to appear here upon being accepted for consideration by working group)

Random numbers as parameters artf6186 :

Description:  .
Actors:       .
Conversation: .
Acceptance:   .
Endorsed by:  .

Looping over float, double values artf6183 :

Description:  Sweeping over double precision values when evaluating the dependence of certain proarrhythmic risk factors on GNaK value.

Parameter name : GNaK = maximal sodium potassium pump current. Typical default_GNaK is 2.724 pA/pF.
Start          : 0.7 * default_GNaK
End            : 1.3 * default_GNaK
Step           : 0.1 * default_GNaK

Description:  Sweeping over single precision values

Constraint specification artf6187 :

Description:  Constraints when evaluating the dependence of a T wave morphology index on the distribution of cell regions across the ventrical wall using nested sweeping.

Parameter name : prop_epi = proportion (%) of epicardial cells in transmural ventricular strand
Start          : 0.7 * default_prop_epi
End            : 1.3 * default_prop_epi
Step           : 0.1 * default_prop_epi

Parameter name : prop_endo = proportion (%) of endocardial cells in transmural ventricular strand  
Start          : 0.7 * default_prop_endo
End            : 1.3 * default_prop_endo
Step           : 0.1 * default_prop_endo

Constraint     : prop_epi + prop_endo < 80  (%)

Self Modifying Sweeps artf6151 :

Description:  . Self modifying nested loops.
// Outer loop variable used as nested loop constraint
     for(int i = 1; i<=3; ++i ){
           for( int j = 0; j<=i; ++j ){
               System.out.println(""+i+" "+j);
           }
     }   

Sample output:
1 0
1 1
2 0
2 1
2 2
3 0
3 1
3 2
3 3
 

Actors:       .
Conversation: .
Acceptance:   .
Endorsed by:  .